Genmab — Januar 2022
-
Holder vejret
-
det ligner en blodrød åbning på mange aktier
-
Fy for den lede. Hvad gør man på en dag som idag udover at kigge væk
-
Afsnit 99 af Investeringspodcasten - Omikron og 'Tip en 20 https://www.proinvestor.com/index.php?p=debat_1&postid=99916
-
Barclays analyst Emily Field reiterated an Overweight rating and DKK3,100.00 price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB). https://www.streetinsider.com/Intl+Ratings/Barclays+Reiterates+Overweight+Rating+on+Genmab+AS+(GEN%3ADC)+(GMAB)/19421625.html?classic=1
-
Klarussen. Virker da fint her?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind